Neuroimaging in European academic neurology: Present status and future organization

European Journal of Neurology

Volumn 5, Issue 1, 1998, Pages 5-15

  Baron, J C ^a,b   Lenzi, G L ^b   Brucke T ^b   Frackowiak, R ^b   Heiss, W D ^b   Pantano, P ^b   Paulson, O B ^b   Rossini, P M ^b   Schoenen, J ^b   Touboul, P J ^b   Vion Dury, J ^b   Von Kummer, R ^b  

^a UNIVERSITÉ DE CAEN   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRONEUROLOGY; EUROPE; IMAGING; NEUROLOGY; NEURORADIOLOGY; NEUROSCIENCE; POSTGRADUATE EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TRAINING;

EID: 6844222851     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1998.510005.x     Document Type: Review

References (69)

1. Ackerman RH (1995). Neurovascular non-invasive evaluation. In: Radiology, Vol. 3. Taveras, Ferrucci (editors). New York: Lippincott-Raven, 1-30.
2. Andersen AR, Hansen BR, Hogenhaven H, Herning M, Paulson O, Dam M (1996). Interictal SPECT of rcbf is of clinical utility in the preoperative evaluation of patients with partial epilepsy. Epilepsy res 25:41-50.
3. Assessment: magnetoencephalography (MEG) (1992). Report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 42:1-4.
4. Assessment: positron emission tomography (1991). Report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 41:163-167.
5. Assessment of brain SPECT (1996). Report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 46:278-285.
6. Bakker D, Pauwels EKJ (1997). Stroke: the role of functional imaging. Euro J Nucl Med 24:2-5.
7. Barker AT, Jalinous R, Freeston IL (1985). Non-invasive magnetic stimulation of human motor cortex. Lancet 1:1106-1107.
8. Baron JC, Von Kummer R, Del Zoppo GJ (1995). Treatment of acute ischemic stroke: challengingthe concept of a rigid and universal time-window. Stroke 26:2219-2221.
9. Baron JC (1996a). Physiological imaging of stroke. Clin Anaesthesiol 10:565-580.
10. Baron JC (1996b). Clinical use of positron emission tomography in cerebrovascular diseases. Neurosurg Clin North Am 7:653-64.
11. Berthezène Y, Nighoghossian N, Meyer R, Damien J, Cinotti L, Adeleine P, Trouillas P, Froment JC (1997). Course of vasomotor reactivity using dynamic susceptibilioty contrast-enhanced MRI in a patient with high-grade internal carotid-artery stenosis. Cerebrovas Dis 7:235-238.
12. Brillman J, Kasdan R, Wechsler LR (1997). The neurologist as neuroimager. Neurology 48:303-311.
13. Brooks DJ (1991). PET: its clinical role in neurology. J Neurol Neurosurg Psych 54:1-5.
14. Cantello R, Gianelli M, Bettucci D, Civardi C, de Angelis MS, Mutani R (1991). Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 41:1449-1456.
15. Castillo M, Kwock L, Mukherji SK (1996). Clinical applications of proton MR spectroscopy. AJNR 17:1-15.
16. Confort-Gouny S, Vion-Dury J, Chabrol B, Nicoli F, Cozzone PJ (1995). Localized proton nmr spectroscopy in x-linked adrenoleukodystrophy. Neuroradiology 37:568-575.
17. 11C-1-methylmethionine. Neurosurgery 40:276-288.
18. Duncan JS (1997). Imaging and epilepsy. Brain 120:339-377.
19. Duncan JS (1996). Magnetic resonance spectroscopy. Epilepsia 37:598-605.
20. Evans AC, Frank JA, Antel J, Miller DH (1997). The role of MRI in clinical trials of multiple sclerosis: comparison of image processing techniques. Ann Neurol 41:125-132.
21. Frackowiak RSJ (1996). Plasticity and the human brain: insights from functional imaging. The Neuroscientist 2:353-362.
22. Frackowiak RSJ, Gadian DG (1996). Functional neuroimaging. In: Neurology in Clinical Practice. Bradley WG, Daroff RB, Fenichel GM, Marsden CD (editors). Boston: Butterworth Heinemann. 577-589.
23. Frackowiak RSJ (1986). PET scanning: can it help resolve management issues in cerebral ischemic disease. Stroke 17:803-807.
24. Ganslandt O, Steinmeier R, Kober H, Vieth J, Kassubek J, Romstöck J, Strauss C, Fahlbusch R (1997). Magnetic source imaging combined with image-guided frameless stereotaxy: a new method in surgery around the motor strip. Neurosurgery 41:621-628.
25. Garcia PA, Laxer KD, van der Grond J, Hugg JW, Matson GB, Weiner MW (1995). Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy. Ann Neurol 37:279-281
26. Gomez CR, Kinkel P, Masdeu JC, Mckinney WM, Polachini I, Tegeler CH, Yadav SS (1995). Guidelines for credentialing in neuroimaging, report from the task force on updating guidelines for credentialing in neuroimaging. Am Acad Neurol, June, pp. 1-5.
27. Grafton ST, Martin NA, Mazziotta JC, Woods RP, Vinuela F, Phelps ME (1994). Localization of motor areas adjacent to arteriovenous malformations. J Neuroimag 4:97-103.
28. Heiss WD, Herholz K (1994). Pathophysiology of brain gliomas assessed by multitracer PET and MRS. In: Clinical PET in Oncology. Matsuzawa T (editor). Singapore: World Scientific Publishers. 91-97.
29. Heiss WD (1995). Assessment of the pathophysiology of stroke by positron emission tomography. In: Quantitative Cerebral Blood Flow Measurements Using Stable Xenon/CT: Clinical Applications. Tomonaga M, Tanaka A, Yonas H (editors). Armonk, New York: Futura. 167-180.
30. Herholz K (1995). FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disorders 9:6-16.
31. Holman BL, Devous MD (1992). Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 33:1888-1904.
32. Karbe H, Herholz K, Kessler J, Wienhard K, Pietrzyk UE, Heiss WD (1997). Recovery of language after brain damage. Adv Neurol 73:347-358.
33. Kordower JH, Freeman TB, Snow BJ, et al. (1995). Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124.
34. Kuikka JT, Belliveau JW, Hari R (1996). Future of functional brain imaging. Eur J Nucl Med 23:737-740.
35. Leblanc R, Meyer E (1990). Functional PET scanning in the assessment of cerebral arteriovenous malformations. J Neurosurg 73:615-619.
36. Lentle B, Aldrich J (1997). Radiological sciences, past and present. Lancet 350:280-285.
37. Levin DC (1994). The practice of radiology by non-radiologists: cost, quality, and utilization issues. Am J Roentgenol 162:513-518.
38. Masdeu JC, Brass LM, Holman BL, Kushner MJ (1977). Brain single-photon emission computed tomography. Neurology 44:1970-1977.
39. Mazziotta JC, Frackowiak RSJ, Phelps ME (1992). The use of positron emission tomography in the clinical assessment of dementia. Sem Nucl Med 22:233-246.
40. Moats RA, Watson L, Shonk T, Tokuyama S, Braslau D, Eto R, Mandigo JC, Ross BD (1995). Added value of automated clinical proton MR spectroscopy of the brain. J Comp Ass Tom 19:480-491.
41. Newberg AB, Alavi A (1996). Alavi: the study of neurological disorders using positron emission tomography and single photon emission computed tomography. J Neurol Sci 135:91-108.
42. Nordberg A (1996). Application of PET in dementia disorders. Acta Neurol Scand (suppl.)168:71-76.
43. Oertel WH, Schwarz J, Tatsch K, Arnold G, Gasser T, Kirsch CM (1993). IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome. Adv Neurol 60:519-524.
44. Pantano P, Formisano R, Ricci M, di Piero V, Sabatini U, Barbanti P, Fiorelli M, Bozzao L, Lenzi GL (1995). Prolonged muscular flaccidity after stroke. Morphological and functional brain alterations. Brain 118:1329-1338.
45. Pantano P, Formisano R, Ricci M, di Piero V, Sabatini U, di Pofi B, Rossi R, Bozzao L, Lenzi GL (1996). Motor recovery after stroke: morphological and functional brain alterations. Brain 119:1849-1857.
46. Papisarda G, Bastings E, Maertens de Noordhout A, Pennisi G, Delwaide PJ (1996). Can motor recovery in stroke patients be predicted by early transcranial magnetic stimulation? Stroke 27:2191-2196.
47. Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M (1994). Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117:847-858.
48. Paulson OB, Lassen NA (1995). How useful are SPECT studies of cerebral blood flow in clinical neurology? In: American Academy of Neurology. Annual Courses. Basic Neurosciences 9-16.
49. Ricci M, Pantano P, Pierallini A, di Stefano D, Santoro A, Bozzao L, Lenzi GL (1996). Relationship between thallium-201 uptake and MRI morphological characteristics of supratentorial glioblastomas. Eur J Nucl Med 23:524-529.
50. Rossini PM, Babiloni F, Bernardi G, Cecchi L, Johnson PB, Malentacca A, Stanzione P, Urbano A (1989). Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients. Electroencephalogr Clin Neurophysiol 74:277-289.
51. Ryding E (1996). SPECT measurements of brain function in dementia; a review. Acta Neurol Scand (suppl.)168:54-58.
52. Sadzot B (1996). Neuroimaging in epilepsy: is there a future for positron emission tomography? Epilepsia 37:511-514.
53. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ (1997). Brain proton MR spectroscopy in HIV-related encephalopathies. identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Human Retrovir 13:1055-1066.
54. Schoenen J (1997). Clinical neurophysiology of headache. Neurologic Clinics 15:85-105.
55. Smith AD, Jobst KA (1996). Use of structural imaging to study the progression of Alzheimer's disease. British Med Bull 52:575-586.
56. Stefan H, Schneider S, Abraham-Fuchs K, Bauer J, Feistel H, Pawlik G, Neubauer U, Rohrlein G, Huk WJ (1990). Magnetic source localization in focal epilepsy. multichannel magnetoencephalography correlated with magnetic resonance brain imaging. Brain 113:1347-1359.
57. Sunshine JH, Bansal S, Evens RG (1993). Radiology performed by non-radiologists in the United States: who does what? Am J Roentgenol 161:419-429.
58. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, di Chiro G (1997). Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516-524.
59. Torres EM, Fricker RA, Hume SP, Myers R, Opacka-Juffry J, Ashworth S, Brooks DJ, Dunnett SB (1995). Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner. Neuroreport 6:2017-2021.
60. Touboul PJ, Rougemont D (1993). Exploration ultrasonore des arteres cervicales et cerebrales: semeilogie et indications dans les accidents ischemiques cerebraux. In: Accidents Vasculaires Cerebraux. Bogousslavsky J, Bousser MG Mas JL (editors). Doin (Paris), pp. 187-201.
61. Traversa R, Cicinelli P, Bassi a. Rossini PM, Bernardi G (1997). Mapping of motor cortical reorganization after stroke. A brain stimulation study with focal magnetic pulses. Stroke 28:110-117.
62. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW (1994). What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J. Neurol 241:354-371.
63. Von Kummer R, Allen KL, Holle R, Bozzao L, Bastianelli S, Manelfe C, Bluhmki E, Ringle BP, Meier D, Hacke W. The significance of computed tomography in stroke prior to thrombolytic treatment. Radiology (in press).
64. Von Kummer R, Bozzao L, Manelfe C (1995). Early CT Diagnosis of Hemispheric Brain Infarction. New York: Springer Heidelberg.
65. Waldemar G (1995). Functional brain imaging with SPECT in normal aging and dementia, methodological, pathophysiological, and diagnostic aspects. Cerehrovasc Brain Metab Rev 7:89-130.
66. Wang Z, Zimmerman RA, Sauter R (1996). Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR 167:191-199.
67. Warach S, Boska M, Welch KMA (1997). Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke. Stroke 28:481-482.
68. Watanabe E, Yamashita Y, Maki A, Ito Y, Koizumi (1996). Non-invasive functional mapping with multi-channel near infra-red spectroscopic topography in humans. Neurosci Lett 205:41-44.
69. Weeks RA, Brooks DJ (1994). Positron emission tomography and central neurotransmitter systems in movement disorders. Fundam Clin. Pharmacol 8:503-517.